Chapter 16
Nanotechnology and Cardiovascular Tissue Engineering
Savneet Kaur,
Upasana Rishiraj,
Savneet Kaur
School of Biotechnology, Gautam Buddha University, Uttar Pradesh, India
Search for more papers by this authorUpasana Rishiraj
School of Biotechnology, Gautam Buddha University, Uttar Pradesh, India
Search for more papers by this authorSavneet Kaur,
Upasana Rishiraj,
Savneet Kaur
School of Biotechnology, Gautam Buddha University, Uttar Pradesh, India
Search for more papers by this authorUpasana Rishiraj
School of Biotechnology, Gautam Buddha University, Uttar Pradesh, India
Search for more papers by this authorBook Editor(s):Hossein Baharvand,
Nasser Aghdami,
Hossein Baharvand
Search for more papers by this authorNasser Aghdami
Search for more papers by this authorSummary
Nanotechnology is the engineering of functional systems at the molecular scale, that is, a few nanometers. It is the manipulation of matter with at least one dimension sized from 1 to 100 nanometers. In recent years, nanotechnological techniques have enabled the manipulation and control of the microcellular environment, which has helped in the construction of complex tissues required for tissue engineering. By recapitulation of such in vivo environments in culture, this technology seems to accommodate a great potential in providing new vistas to cardiovascular tissue engineering. The present review summarizes various bioengineering techniques employed for repair of the heart cells and finally provides an overview of the current use of nanotechnology in cardiovascular tissue engineering.
References
- Murry CE, H Reinecke and LM Pabon (2006). Regeneration gaps: observations on stem cells and cardiac repair. Journal of the American College of Cardiology 47: 1777–1785.
- Koh GY, MG Klug, MH Soonpaa and LJ Field (1993). Differentiation and long-term survival of C2C12 myoblast grafts in heart. Clinical Investigation 92: 1548–1554.
- Jackson KA, SM Majka, H Wang, J Pocius, CJ Hartley, MW Majesky, ML Entman, LH Michael, KK Hirschi and MA Goodell (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. Clinical Investigation 107: 1395–1402.
- Orlic D, J Kajstura, S Chimenti, I Jakoniuk, SM Anderson, B Li, J Pickel, R McKay, B Nadal-Ginard, DM Bodine, A Leri et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410: 701–705.
- Mathiasen AB, E Jørgensen, AA Qayyum, M Haack-Sørensen, A Ekblond and J Kastrup (2012). Rationale and design of the first randomized, double-blind, placebo- controlled trial of intramyocardial injection of autologous bone-marrow derived mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). American Heart 164: 285–289.
- Kuraitis D, P Zhang, Y Zhang, DT Padavan, K McEwan, T Sofrenovic, D McKee, J Zhang, M Griffith, X Cao, A Musarò, et al. (2011). A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. European Cell Materials 22: 109–123.
- Zisa D, A Shabbir, M Mastri, T Taylor, I Aleksic, M McDaniel, G Suzuki and T Lee (2011). Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. American J Physiology Heart Circulation Physiology 301: H2422–H2432.
- Beltrami AP, L Barlucchi, D Torella, M Baker, F Limana, S Chimenti, H Kasahara, M Rota, E Musso, K Urbanek, A Leri, J Kajstura, et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763–76.
- Mummery F (2009). Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. Cell Biochemistry 107: 592–599.
- Mummery CL-JZ, ES Ng, DA Elliott, AG Elefanty and TJ Kamp (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circulation Research 111: 344–358.
- Asahara T, T Murohara, A Sullivan, M Silver, R van der Zee, T Li, B Witzenbichler, G Schatteman and JM Isner (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964–967.
- Kalka C, H Masuda, T Takahashi, WM Kalka-Moll, M Silver, M Kearney, T Li, JM Isner and T Asahara (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Sciences of the USA 97: 3422–3427.
- Kawamoto A, HC Gwon, H Iwaguro, JI Yamaguchi, S Uchida, H Masuda, M Silver, H Ma, M Kearney, JM Isner and T Asahara (2001). Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634–637.
- Kaur S, TR Santhosh Kumar, A Uruno, A Sugawara, K Jayakumar and CC Kartha (2009). Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study. Basic Research in Cardiology 104: 739–749.
- Shimizu T, M Yamato, Y Isoi, T Akutsu, T Setomaru, K Abe, A Kikuchi, M Umezu and T Okano (2002). Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circulation Research 90: e40–e48.
- Bel A, V Planat-Bernard, A Saito, L Bonnevie, V Bellamy, L Sabbah, L Bellabas, B Brinon, V Vanneaux, P Pradeau, S Peyrard, et al. (2010). Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 122: S118–S123.
- Stevens KR, L Pabon and V Muskheli (2009). Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Engineering Part A 15: 1211–1222.
- Ott HC, TS Matthiesen, S-K Goh, LD Black, SM Kren, TI Netoff and DA Taylor (2008). Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nature Medicine 14: 213–221.
- Robinson KA, J Li, M Mathison, A Redkar, J Cui, NA Chronos, RG Matheny and SF Badylak (2005). Extracellular matrix scaffold for cardiac repair. Circulation 112: I135–I143.
- Rave S and EL Chaikof (2010). Biomaterials for vascular tissue engineering. Regenerative Medicine 5: 107–120.
- Peppas NA, JZ Hilt, A Khademhosseini and R Langer (2006). Hydrogels in biology and medicine: from molecular princi-ples to bionanotechnology. Advanced Materials 18: 1345.
- Cheng M, H Park, GC Engelmayr, M Moretti and LE Freed (2007). Effects of regulatory factors on engineered cardiac tissue in vitro. Tissue Engineering 13: 2709.
- Zimmermann W-H, K Schneiderbanger, P Schubert, M Didie, F Munzel, JF Heubach, S Kostin, WL Neuhuber and T Eschenhagen (2002). Tissue engineering of a differentiated cardiac muscle construct. Circulation Research 90: 223–230.
- Korecky B, CM Hai and K Rakusan (1982). Functional capillary density in normal and transplanted rat hearts. Canadian Journal of Physiology Phamacology 60: 23–32.
- Radisic M, H Park, TP Martens, JE Salazar-Lazaro, W Geng, Y Wang, R Langer, LE Freed and G Vunjak-Novakovic (2008). Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. Biomedical Materials 86: 713–724.
- Sekine H, T Shimizu, K Hobo, S Sekiya, J Yang, M Yamato, H Kurosawa, E Kobayashi and T Okano (2008). Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118: S145–S152.
- Jay SM, BR Shepherd, JW Andrejecsk, TR Kyriakides, JS Pober and WM Saltzman (2010). Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization. Biomaterials 31: 3054–3062.
- Saif J, TM Schwarz, DY Chau, J Henstock, P Sami, SF Leicht, PC Hermann, S Alcala, F Mulero, KM Shakesheff, C Heeschen and A Aicher (2010). Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arteriosclerosis, Thrombosis, and Vascular Biology 30: 1897–1904.
- Martinez EC, J Wang, SU Gan, R Singh, CN Lee and T Kofidis (2010). Ascorbic acid improves embryonic cardiomyoblast cell survival and promotes vascularization in potential myocardial grafts in vivo. Tissue Engineering Part A 16: 1349–1361.
- Smart N, CA Risebro, JE Clark, E Ehler, L Miquerol, A Rossdeutsch, MS Marber and PR Riley (2010). Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart. Annals of the New York Academy of Sciences 1194: 97–104.
- Kumbar S, L Nair, S Bhattacharyya and C Laurencin (2010). Contribution of extracellular matrix to the mechanical properties of the heart. Mol Cell Cardiology 48: 490–496.
- Kim DH, EA Lipke, P Kim, R Cheong, S Thompson, M Delannoy, KY Suh, L Tung and A Levchenko (2010). Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proceedings of the National Academy of Sciences of the USA 107: 565–570.
- Kumbar S, L Nair, S Bhattacharyya and C Laurencin (2006). Polymeric nanofibers as novel carriers for the delivery of therapeutic molecules. Nanoscience Nanotechnology 6: 2591.
-
Ma PX and Zhang R (1999). Synthetic nano-scale fibrous extracellular matrix. Biomedical Materials Research Part A 46: 60.
10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H CAS PubMed Web of Science® Google Scholar
- Matthews JA, GE Wnek, DG Simpson and GL Bowlin (2002). Electrospinning of collagen nanofibers. Biomacromolecules 3: 232–238.
- Zhang SG (2003). Fabrication of novel biomaterials through molecular self-assembly. Nature Biotechnology 21: 1171–1178.
- Woo K, V Chen and PX Ma (2003). Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. Biomaterial Research Part A 67: 531–537.
- Tayalia P and D Mooney (2009). Controlled growth factor delivery for tissue engineering. Advanced Materials 21: 3269–3285.
- Chew SY, T Hufnagel, C Lim and KW Leong (2006). Mechanical properties of single electrospun drug-encapsulated nanofibres. Nanotechnology 17: 3880–3891.
- Buttafoco L, NG Kolkman, P Engbers-Buijtenhuijs, AA Poot, P Dijkstra, I Vermes and J Feijen (2006). Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 27: 724–734.
- Van de Witte P, P Dijkstra, J Van den Berg and J Feijen (1996). Phase separation processes in polymer solutions in relation to membrane formation. Membrane Science 117: 1–31.
-
Mikos AG and J Temenoff (2000). Formation of highly porous biodegradable scaffolds for tissue engineering. Electron Journal of Biotechnology 3: 114–119.
10.2225/vol3-issue2-fulltext-5 Google Scholar
- Hartgerink J, E Beniash and S Stupp (2001). Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 294: 1684–1688.
- Dahlin RL, FK Kasper and AG Mikos (2011). Polymeric nanofibers in tissue engineering. Tissue Engineering Part B 17: 349–364.
- Prabhakaran MP, D Kai, L Ghasemi-Mobarakeh and S Ramakrishna (2011). Electrospun biocomposite nanofibrous patch for cardiac tissue engineering. Biomedical Materials 6: 055001.
- Stout DA, J Yoo, AN Santiago-Miranda and TJ Webster (2012). Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular application. International Journal of Nanomedicine 7: 5653–5669.
- Ravichandran R, CCh Ng, S Liao, D Pliszka, M Raghunath, S Ramakrishna and CK Chan (2012). Biomimetic surface modification of titanium surfaces for early cell capture by advanced electrospinning. Biomedical Materials 7: 015001.
- Prabhakaran MP, AS Nair, D Kai and S Ramakrishna (2012). Electrospun composite scaffolds containing poly(octanediol-co-citrate) for cardiac tissue engineering. Biopolymers 97: 529–538.
- Hosseinkhani H, M Hosseinkhani, S Hattori, R Matsuoka and N Kawaguchi (2010). Micro and nano-scale in vitro 3D culture system for cardiac stem cells. Biomedical Materials Research A 94: 1–8.
- Hussain A, G Collins, D Yip and CH Cho (2013). Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds. Biotechnology and Bioengineering 110: 637–647.
- Smith AW, CE Segar, PK Nguyen, MR MacEwan, IR Efimov and DL Elbert (2012). Long-term culture of HL-1 cardiomyocytes in modular poly(ethylene glycol) microsphere-based scaffolds crosslinked in the phase-separated state. Acta Biomaterialia 8: 31–40.
- Kim DH, EA Lipke, P Kim, R Cheong, S Thompson, M Delannoy, KY Suh, L Tung and A Levchenko (2010). Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proceedings of the National Academy of Sciences of the USA 107: 565–670.
- Hashi CK, Y Zhu, GY Yang, WL Young, BS Hsiao, K Wang, B Chu and S Li (2007). Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proceedings of the National Academy of Sciences of the USA 104: 11915–11920.
- He W, Z Ma, T Yong, WE Teo and S Ramakrishna (2005). Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials 26: 7606–7615.
- Hajiali H, S Shahgasempour, MR Naimi-Jamal and H Peirovi (2011). Electrospun PGA/gelatine nanofibrous scaffolds and their potential application in vascular tissue engineering. International Journal of Nanomedicine 6: 2133–2141.
- Montero RB, X Vial, DT Nguyen, S Farhand, M Reardon, SM Pham, G Tsechpenakis and FM Andreopoulos (2012). bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis. Acta Biomaterialia 8: 1778–1791.
- Wittmer CR, JA Phelps, WM Saltzman and PR Van Tassel (2007). Fibronectin terminated multilayer films: protein adsorption and cell attachment studies. Biomaterials 208: 851–860.
- Yin A, K Zhang, MJ McClure, C Huang, J Wu, J Fang, X Mo, GL Bowlin, SS Al-Deyab and M El-Newehy (2013). Electrospinning collagen/chitosan/poly(L-lactic acid-co-ϵ-caprolactone) to form a vascular graft: mechanical and biological characterization. Biomedical Materials Research A 101: 1292–1301.
- Miller DC, KM Haberstroh and TJ Webster (2007). PLGA nanometer surface features manipulate fibronectin interactions for improved vascular cell adhesion. Biomedical Materials Research A 81: 678–684.
- Tillman BW, SK Yazdani, SJ Lee, RL Geary, A Atala and JJ Yoo (2009). The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials 30: 583–588.
- Zhang M, Z Wang, Z Wang, S Feng, H Xu, Q Zhao, S Wang, J Fang, M Qiao and D Kong (2011). Immobilization of anti-CD31 antibody on electrospun poly(ϵ-caprolactone) scaffolds through hydrophobins for specific adhesion of endothelial cells. Colloids Surfaces B Biointerfaces 15: 32–39.
- Hu J, X Sun, H Ma, C Xie, YE Chen and PX Ma (2010). Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials 31: 7971–7977.
- Xie C, J Hu, H Ma, J Zhang, LJ Chang, YE Chen, and PX Ma (2011). Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds. Biomaterials 32: 4369–4375.
- Odedra D, LL Chiu, M Shoichet and M Radisic (2011). Endothelial cells guided by immobilized gradients of vascular endothelial growth factor on porous collagen scaffolds. Acta Biomaterialia 7: 3027–3035.
- Johnson TD, SY Lin and KL Christman (2011). Tailoring material properties of a nanofibrous extracellular matrix derived hydrogel. Nanotechnology 22: 494015.
- Lin YD, CY Luo, YN Hu, ML Yeh, YC Hsueh, MY Chang, DC Tsai, JN Wang, MJ Tang, EI Wei, et al. (2012). Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair. Science Translational Medicine 4: 146ra109.
- Lu H ZF, T Qiao, C Liu, Z Gu and C Liu (2009). Effects of nanoporous PLLA scaffold on late endothelial progenitor cells behavior. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 23: 166–172.
- Alobaid N, KM Sales, B Ramesh, RY Kannan, G Hamilton and AM Seifalian (2006). Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. European Journal of Vascular and Endovascular Surgery 32: 76–83.
- Webber MJ, J Tongers, MA Renault, JG Roncalli, DW Losordo and SI Stupp (2010). Development of bioactive peptide amphiphiles for therapeutic cell delivery. Acta Biomaterialia 6: 3–11.
